Abstract:Background: There are currently no available standard drugs treating human papillomavirus (HPV) infection, especially for patients with low-grade cervical lesion. Several therapies are explored but the results are inconclusive. The objective of this study was to evaluate the efficacy of reported non-invasive treatments in patients with HPV infection and cervical lesions by meta-analysis. Methods: A comprehensive search of prospective and randomized studies published from April 2000 to April 2020 was conducted in electronic databases. The statistical analyses of the pooled risk ratios (RRs) and the corresponding 95% confidence intervals (95% CIs) were performed using the Revman 5.2 software. Results: Twelve articles including 12 randomized controlled studies and 1 prospective controlled randomized pilot study were enrolled. Therapeutic medications included biological and herbal regimen, interferon regimen and probiotics. The meta-analysis showed the experimental treatments had a statistically significant improvement in HPV clearance rate compared with the controls (RR = 0.71, 95% CI [0.63, 0.80], P < .00001); subgroup analyses stratified by regimen categories were consistent with results in the overall group. Treatment using biological and herbal regimen, interferon regimen or probiotics also resulted in a beneficial outcome in regression rate of cervical lesions compared with the controls (RR = 0.55, 95% CI [0.39, 0.79], P = .001). The trend was more favorable in the probiotics than that in the biological and herbal regimen (RR 0.48 vs 0.72). Conclusion: Treatment of biological and herbal regimen, interferon regimen and probiotics benefit patients who have HPV infection and cervical lesions. Both the clearance of HPV and regression of cervical lesions are significant. More studies with less heterogeneity are needed to draw a concrete conclusion.

Research Progress of Natural Source Potential Drugs in Reversing Cervical Precancerous Lesions and Human Papillomavirus Negative Conversion

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

Development of Human Papillomavirus Detection

[Progress of study on anti-human cervical papilloma virus infection with Chinese and Western medicine]

Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer

Research advance of traditional Chinese medicines and components in the treatment of HPV induced cervical cancer

Human Papillomavirus Associated Cervical Lesion: Pathogenesis and Therapeutic Interventions

Clearance of Human Papillomavirus Infection in Patients with Cervical Intraepithelial Neoplasia A Systemic Review and Meta-Analysis

Clearance of Human Papillomavirus Infection in Patients with Cervical Intraepithelial Neoplasia

Research progress on human papillomavirus-negative cervical cancer: A review

Targeting HPV for the prevention, diagnosis, and treatment of Cervical Cancer

The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy

Research progress and preventive strategy of HPV and cervical cancer and other related cancers

Research Progress of HPV L1 Capsid Protein in Prediction of Cervical Lesions

Advances in cervical cancer: current insights and future directions

[Research progression on triage of human papillomavirus positive women]

Current Strategies Against Persistent Human Papillomavirus Infection (Review)

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review

Reverse pharmacology based clinical protocols for noninvasive integrative management of low grade cervical precancer lesions: Rationale and outcomes

Analysis of the current status of research on human papillomavirus-associated head and neck cancers based on recent Chinese literature

Traditional Chinese medicine for human papillomavirus (HPV) infections: A systematic review